Valuation: Center Laboratories, Inc.

Market Cap 27.92B 869M 759M 702M 648M 1.22B 83.44B 1.24B 8.37B 3.28B 40.86B 3.26B 3.19B 141B P/E 2024
-28.2x
P/E 2025 3.64x
Enterprise Value 31.96B 994M 869M 803M 742M 1.4B 95.52B 1.42B 9.58B 3.76B 46.77B 3.74B 3.65B 161B EV / Sales 2024
22.3x
EV / Sales 2025 23.1x
Free-Float
73.35%
Yield 2024
1.71%
Yield 2025 4.21%
1 day-1.71%
1 week-5.32%
Current month-1.97%
1 month-0.66%
3 months-7.08%
6 months-9.22%
Current year-10.10%
1 week 37.05
Extreme 37.05
39.5
1 month 36.8
Extreme 36.8
40.55
Current year 36.8
Extreme 36.8
51.4
1 year 33.1
Extreme 33.1
51.4
3 years 29.12
Extreme 29.1236
58.79
5 years 29.12
Extreme 29.1236
58.79
10 years 20.99
Extreme 20.9884
64.21
Manager TitleAgeSince
Chief Executive Officer - 02/08/1998
Director of Finance/CFO - 07/12/2022
Chief Tech/Sci/R&D Officer - 30/06/1983
Director TitleAgeSince
Chairman - 29/11/2022
Director/Board Member 61 13/06/2010
Director/Board Member - 13/06/2010
Change 5-day change 1-year change 3-year change Capi.($)
-1.71%-5.32%+4.93%-23.01% 869M
-2.48%-6.72%+44.19%+156.43% 1,028B
-1.52%-5.01%+61.87%+58.79% 611B
-1.30%-3.88%+27.81%+79.97% 432B
+0.11%-2.27%+28.35%+22.04% 323B
-0.60%-3.34%+26.69%+43.31% 277B
+0.57%-12.70%+18.45%+21.88% 257B
+0.59%-0.76%-25.95%-40.17% 217B
-1.44%-3.49%+19.60%+56.20% 192B
-1.04%-4.63%+16.01%+68.47% 161B
Average -0.32%-5.25%+22.20%+44.39% 349.92B
Weighted average by Cap. -0.17%-5.52%+33.52%+76.92%

Financials

2024 2025
Net sales 1.62B 50.34M 43.99M 40.66M 37.57M 70.75M 4.84B 72.03M 485M 190M 2.37B 189M 185M 8.15B 1.52B 47.17M 41.22M 38.11M 35.21M 66.3M 4.53B 67.5M 454M 178M 2.22B 177M 173M 7.64B
Net income -1.1B -34.34M -30.01M -27.74M -25.63M -48.26M -3.3B -49.14M -331M -130M -1.62B -129M -126M -5.56B 9.32B 290M 253M 234M 216M 408M 27.86B 415M 2.79B 1.1B 13.64B 1.09B 1.07B 46.98B
Net Debt 4.48B 139M 122M 113M 104M 196M 13.39B 199M 1.34B 527M 6.56B 524M 512M 22.57B 4.04B 126M 110M 102M 93.85M 177M 12.08B 180M 1.21B 475M 5.91B 472M 462M 20.36B
Logo Center Laboratories, Inc.
Center Laboratories Inc is a Taiwan-based company engaged in the development of pharmaceutical products. The Company's products mainly focus on internal liquids, including syrups, suspensions, liquids and other dosage forms. Pharmacological classifications include respiratory tract therapeutics such as cough suppressants, sputum expectorants, asthma medications, and runny nose relief, while antipyretic and analgesic medications and gastrointestinal medications are also in great demand, and a variety of internal liquids and lozenges for the treatment of central nervous system (CNS) such as epilepsy, dysphoria, dementia, and Parkinson's disease have already been introduced into the market. The Company is a specialized manufacturer of internal liquid.
Employees
-
Date Price Change Volume
14/07/26 NT$37.40 -1.71% 2,082,363
13/07/26 NT$38.05 -2.31% 2,309,344
09/07/26 NT$38.95 -1.02% 1,354,313
08/07/26 NT$39.35 -0.38% 2,447,035
07/07/26 NT$39.50 -0.75% 2,544,596
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. 4123 Stock